Clinical Study

A011401-Randomized Phase III Trial Evaluating The Role Of Weight Loss In Adjuvant Treatment Of Overweight And Obese Women With Early Breast Cancer.

Posted Date: May 15, 2019

  • Investigator: Neetu Radhakrishnan
  • Specialties: Breast Cancer, Cancer, Oncology
  • Type of Study: Observational/Survey

To compare the effect of a supervised weight loss intervention plus health education materials versus health education materials alone upon invasive disease free survival (iDFS) in overweight (BMI 27-29.9 kg/m2) and obese (BMI =30kg/m2) women diagnosed with HER-2 negative, stage II and III breast cancer.

Criteria:

To Be Eligible: Patients Must Be 18+ Years Of Age, Patients Must Be Overweight (Bmi > 27) Or Obese Women With Stage 2 Or 3 Breast Cancer, Not Diabetic, No Other Malignancy In Past 4 Years

Keywords:

Breast Cancer, Breast, Cancer, Phase Iii

For More Information:

Uc Cancer Institute
513-584-7698
cancer@uchealth.com


  • This contact page is monitored Monday – Friday during business hours, 8 am to 5 pm EST. Do not rely on communication through this website for medical treatment or care. This website is not designed for such purposes.
    For questions regarding clinical studies at UC Health, contact us at ResearchStudies@UCHealth.com or (513) 245-3417.